COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6) (TMUVA-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00440544
Recruitment Status : Terminated (Safety Issues)
First Posted : February 27, 2007
Last Update Posted : November 3, 2008
Statens Serum Institut
Novartis Vaccines
European Union
Information provided by:
St George's, University of London

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 2007
Actual Study Completion Date : February 2008